Total raised
—
Stage
Pre-Funding
Founded
2019
Headcount
4
HQ
Hod HaSharon
Sector
Health Tech & Life Sciences
About
Nanorobotics is a preclinical-stage startup on a mission to eradicate cancer by harnessing the power of its breakthrough, patented light-activated nanomolecular platform technology.
Nanorobotics platforms leverage the unique characteristics of a Molecular Nanomachines (MNMs), which can drill mechanically through the cell membrane, to develop a pipeline of safe and effective molecular therapies for treating cancers that have shown resistance to conventional therapies.
Nanorobotics leading molecule, MNM96, exhibits an excellent preclinical efficacy and safety profile and is well positioned to advance toward the first human clinical trials in 2025.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary mission of Nanorobotics?
- Nanorobotics is a preclinical-stage startup focused on eradicating cancer using its patented light-activated nanomolecular platform technology.
- What is the current operational status of Nanorobotics?
- Nanorobotics is currently inactive, having ceased operations in November 2024.
- What is the core technology developed by Nanorobotics?
- Nanorobotics develops Molecular Nanomachines (MNMs) that can mechanically drill through cell membranes to deliver molecular therapies for cancers resistant to conventional treatments.
- What is Nanorobotics' leading product molecule?
- Nanorobotics' leading molecule is MNM96, which has shown excellent preclinical efficacy and safety.
- When was Nanorobotics founded?
- Nanorobotics was founded in May 2019.
- What is the employee count of Nanorobotics?
- Nanorobotics has 4 employees.
- What is the total funding raised by Nanorobotics?
- Nanorobotics has not raised any external funding, with a total raised amount of $0 USD.
- What is the primary sector of Nanorobotics?
- Nanorobotics operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Who is a co-founder of Nanorobotics?
- Yossi Keret is a founder of Nanorobotics.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalscancer-therapyoncologytreatmentstargeted-therapybiotechnologycell-therapynanotechnology